Formulating for the Future of Transplant Patient Therapy
Veloxis is a specialty pharmaceutical company committed to improving the lives of transplant patients. Our unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs.
Veloxis is an international company with headquarters in Hørsholm, Denmark, and a fully owned subsidiary in Edison, New Jersey, USA.
Veloxis is committed to patient access and financial support for kidney transplant patients. Learn more about our prescription cost savings programs, click here
UK: +44(0)20 7136 2055
US: +1718 354 1359
Denmark: +4538 48 75 13
Start time: 3:00 pm CET
Please dial in for your pre-conference 30 prior to the scheduled start time.
Confirmation Code: 1720884